Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
Open Access
Abstract
Objectives: To investigate whether the adherens junction protein vascular endothelial cadherin (VE-cadherin) is released during Shiga toxin 2 producing Escherichia coli (STEC) infection with haemolytic uraemic syndrome (HUS) and thus could be used to assist diagnosis. Design: Using data from the large 2011 STEC outbreak in northern Europe, we determined VE-cadherin plasma concentrations in 356 patients distributed over three patient cohorts: patients with STEC infection accompanied by HUS (STEC-HUS), STEC patients without HUS (STEC) and control patients with diarrhoea but without STEC infection. We then looked for associations between VE-cadherin concentrations and disease severity defined by changes in lactate dehydrogenase, haemoglobin, creatinine, platelet count, haptoglobin and neurological symptoms. Setting: This study was conducted at the University Medical Center Hamburg-Eppendorf, Germany. Participants: 79 STEC-HUS patients, 77 STEC patients and 200 control patients were enrolled in the study. Results: We analysed 864 specimens (207 STEC, 449 STEC-HUS and 208 controls) in total. At admission, VE-cadherin concentration tended to be lower in STEC-HUS patients compared to other patients. However, HUS patients later showed an increase in VE-cadherin concentrations with prolonged elevation beyond remission. This pattern clearly differs from that observed in non-HUS patients. Conclusions: VE-cadherin concentrations are elevated in STEC-HUS patients and might be a biomarker reflecting endothelial damage in patients with HUS.Keywords
This publication has 30 references indexed in Scilit:
- Soluble Vascular Endothelial‐Cadherin Levels in Patients With Sepsis Treated With Direct Hemoperfusion With a Polymyxin B‐immobilized Fiber ColumnTherapeutic Apheresis and Dialysis, 2014
- Thrombotic microangiopathy and associated renal disordersNephrology Dialysis Transplantation, 2012
- Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major playerTrends in Cell Biology, 2009
- Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coliEmerging Infectious Diseases, 2008
- A Case of Hemolytic Uremic Syndrome Caused by Escherichia coli O104:H4Yonsei Medical Journal, 2006
- Mature Vascular Endothelium Can Give Rise to Smooth Muscle Cells via Endothelial-Mesenchymal TransdifferentiationCirculation Research, 2002
- Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cellsAmerican Journal of Physiology-Renal Physiology, 2002
- Pathogenesis of Shiga toxin-induced hemolytic uremic syndromePediatric Nephrology, 2001
- Many cell types are Shiga toxin targetsKidney International, 2000
- Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammationCardiovascular Research, 1999